ZELLUNA ZLNA ADDITIONAL REGULATED INFORMATION REQUIRED TO BE DISCLOSED UNDER THE LAWS OF A MEMBER STATE

Zelluna ASA - Ex. date

04. November 2025 kl. 07:00

Original kilde

The shares in Zelluna ASA will from today, 4 November 2025, be traded exclusive of the right to participate in the contemplated subsequent offering announced on 3 November 2025.

This information is published in accordance with the requirements of the Continuing Obligations for Euronext Oslo Børs.

Zelluna ASA - Ex. date

Andre nyheter

Zelluna ASA: Approval and publication of prospectus

Zelluna Reaches Major Milestone and Submits Clinical Trial Application in the UK for First-in-Human Study of ZI-MA4-1 (ZIMA-101), the World's First MAGE-A4-Targeting TCR-NK Cell Therapy for Solid Tumours

Zelluna har nådd en viktig milepæl og innleverer søknad om klinisk studie i Storbritannia for første studie på mennesker av ZI-MA4-1 (ZIMA-101), verdens første MAGE-A4-rettede TCR-NK celleterapi for solide kreftformer.

🍪 Vi bruker informasjonskapsler

Informasjonskapsel-innstillinger